and J. Moon, "Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia," Expert Review of Cardiovascular Therapy, vol. 8, no. 8, pp. 1079-1090, 2010.Gotto AM; Moon J.Pitavastatin for the treatment of primary hyperlipidemia and mixed dyslipidemia.Ex- pert Rev Cardiovasc...
Primary Hyperlipidemia and Mixed DyslipidemiaDrug TrialsShow entriesDrugDrug NamePhaseStatusCount DB01076 Atorvastatin 3 Completed 1 DB09303 Evolocumab 3 Completed 1 Showing 1 to 2 of 2 entries ‹ 1 › Stay up-to-date with the latest from DrugBank! Subscribe Downloads Data Library Academic...
Childhood with CD Acquired CD is a more prevalent form of dyslipidemia in childhood.113 Diagnosis of familial combined hyperlipidemia (FH) requires the presence of increased Apo-B and sd-LDL particles in the patient and in at least two family members and one first-degree relative with the ...
These effects are pointing out that PS-HOSO may serve as a functional ingredient for metabolic syndrome or diabetic sufferers, which not only influences body weight, but also prevents or reverses insulin resistance and hyperlipidemia.Background Metabolic syndrome represents a cluster of metabolic ...
These effects are pointing out that PS-HOSO may serve as a functional ingredient for metabolic syndrome or diabetic sufferers, which not only influences body weight, but also prevents or reverses insulin resistance and hyperlipidemia.Background Metabolic syndrome represents a cluster of metabolic ...
Incidence of dyslipidemia in the overweight participants was riskier than in the obese: hypercholesterolemia (TC: 8.5 vs. 6.8%), higher TGC (27.3 vs. 16.9%), higher LDLC (25.0 vs. 7.5%) and low HDLC (51.0 vs. 40.2%) per each respective population. Finally, the incidence of hypercreatine...